Shares of Harte Hanks Inc (NYSE:HHS) have received an average broker rating score of 1.00 (Strong Buy) from the one brokers that cover the company, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy recommendation.
Brokers have set a one year consensus target price of $11.00 for the company, according to Zacks. Zacks has also given Harte Hanks an industry rank of 182 out of 256 based on the ratings given to related companies.
Separately, ValuEngine lowered Zosano Pharma from a “buy” rating to a “hold” rating in a research report on Wednesday, May 1st.
Shares of Harte Hanks stock traded up $0.03 on Friday, hitting $2.82. 970 shares of the company’s stock traded hands, compared to its average volume of 3,160. The firm has a market capitalization of $17.55 million, a PE ratio of -3.07 and a beta of 1.07. The business’s 50-day simple moving average is $2.68. Harte Hanks has a 52-week low of $2.20 and a 52-week high of $10.50.
Harte Hanks (NYSE:HHS) last announced its quarterly earnings data on Wednesday, May 8th. The business services provider reported ($1.48) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.77) by ($0.71). The business had revenue of $59.15 million during the quarter, compared to analysts’ expectations of $57.50 million.
About Harte Hanks
Harte Hanks, Inc provides various multi-channel marketing services in the United States and internationally. The company provides agency services, such as customer engagement solutions in direct and digital communications for consumer and business-to-business markets; digital services, including search engine management, display, digital analytics, Website development and design, digital strategy, social media, email, e-commerce, and interactive relationship management services; and database marketing and business-to-business lead generation solutions that offer insight and analytics, customer data integration, and marketing communications tools.
Featured Story: Institutional Investors
Get a free copy of the Zacks research report on Harte Hanks (HHS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Harte Hanks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Harte Hanks and related companies with MarketBeat.com's FREE daily email newsletter.